SavedAdd your journal

Journals / Ağrı / 2008 / Cilt: 20 - Sayı: 1

Fibromyalgia syndrome from the perspective of neuropathic pain

Nöropatik ağrı açısından fibromyalji sendromu

Sibel EYİGÖR
Yeşim KİRAZLI
Journal
Ağrı
Pages
8–12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, a synthesis of the information about how FMS is related to neuropathic pain syndromes is provided.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Fibromyalgia Syndrome from the Perspective of Neuropathic Pain Fibromyalgia syndrome (FMS) is one of the several chronic pain syndromes and have been proposed to reflect some primary abnormality of the nervous system.
📊
Key Findings & Data:Patients with FMS display common clinical features with neuropathic pain.
💡
Conclusion & Impact:In this review, a synthesis of the information about how FMS is related to neuropathic pain syndromes is provided.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Nevralji · Fibromiyalji · Ağrı

Abstract

Fibromyalgia Syndrome from the Perspective of Neuropathic Pain Fibromyalgia syndrome (FMS) is one of the several chronic pain syndromes and have been proposed to reflect some primary abnormality of the nervous system. Patients with FMS display common clinical features with neuropathic pain. The responsible mechanisms for symptoms and signs are still unknown. Mounting evidence was shown for central pain processing abnormalities in almost all FMS patients. These anomalies including hyperalgesia, allodynia, abnormal activation of pain-related brain regions and abnormal temporal summation of second pain in FMS patients strongly indicate a neuropathic pain syndrome. This new information led to the proposal that FMS may be a neuropathic pain syndrome maintained by central nervous system sensitization and sympathetic hyperactivity. This different perspective on FMS opens new avenues for research and treatment. In this review, a synthesis of the information about how FMS is related to neuropathic pain syndromes is provided.

Özet

Klinik kullanımda lehte sonuçları olmasına rağmen, migren tedavisinde büyük oksipital sinir bloğunun (GON) etkisine dair az sayıda kanıt bulunmaktadır. Bir ön çalışmayla migren ataklarının önlenmesinde % 0,5 Fibromyalji sendromu (FMS), sinir sistemindeki primer anormalliklerin kliniğe yansıması ile karşımıza çıkan kronik ağrı sendromlarından biridir. FMS’lu hastalar, nöropatik ağrının yaygın klinik özelliklerini göstermektedirler. Bu semptom ve bulguları açıklayacak mekanizma halen anlaşılmış değildir. Santral ağrının hiperaljezi, allodini, ağrı ilişkili beyin bölgelerinin anormal aktivasyonu, anormal temporal sumasyon gibi nöropatik ağrı sendromu konusunda güçlü kanıtlara neden olan bir takım anormallikleri, FMS’lu hastaların çoğunda gözlenmektedir. Bu yeni bilgiler, santral sinir sisteminde sensitizasyon ve sempatik hiperaktiviteyle ilişkili, FMS’unun nöropatik ağrı sendromu olabileceğini düşündürmektedir. Bu farklı bakış açısı, tedavi ve çalışmalar için yeni kapılar açılmasına neden olmaktadır. Bu derlemede, FMS’unun nasıl nöropatik ağrı sendromu ile ilişkilendirildiğine dair bilgilerin sentezi yapılacaktır.

🔖

Cite This Article

EYİGÖR, S., KİRAZLI, Y. (2008). Fibromyalgia syndrome from the perspective of neuropathic pain. Ağrı, Cilt: 20 - Sayı: 1, 8–12. https://ajindex.com/articles/201677

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Arnold LM,Goldenberg DL,Stanford SB,Lalonde JK, Sandhu HS, Keck PE Jr, Welge JA, Bishop F, Stanford KE, Hess EV, Hudson JI. Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial. Arthritis Rheum.2007; 56: 1336-44
  2. Bengtsson A, Bengtsson M. Regional sympathetic blockade in primary fibromyalgia. Pain.1988; 33: 161-7. Bennett R. Fibromyalgia: present to future. Curr Pain Headache Rep. 2004; 8: 379-84.
  3. Bomholt SF, Mikkelsen JD, Blackburn-Munro G. Normal hypot halamo-pituitary-adrenal axis function in a rat model of peripheral neuropathic pain. Brain Res. 2005; 1044: 216-26.
  4. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, et al. Influence of life stress on depression: modera tion by a polymorphism in the 5-HTT gene. Science.2003; 301: 386-9. Clauw DJ. Elusive syndromes: treating the biologic basis of fibromyalgia and related syndromes. Cleve Clin J Med. 2001 Oct;68(10):830, 832-4.
  5. Clauw DJ, Crofford LJ. Chronic widespread pain and fibromyalgia:what we know, and what we need to know. Best Pract Res Clin Rheumatol 2003; 17: 685-701.
  6. Cohen H, Neumann L, Kotler M, Buskila D. Autonomic nervous system derangement in fibromyalgia syndrome and related disorders.Isr Med Assoc J. 2001; 3: 755-60.
  7. Cohen H, Buskila D, Neumann L, Ebstein RP. Confirmation of an association between fibromyalgia and serotonin transporter promoter region (5- HTTLPR) polymorphism, and relationship to anxiety-related personality traits. Arthritis Rheum. 2002; 46: 845-7.
  8. Cohen S, Abdi S. Central pain. Curr Opin Anaesthesiol 2002; 15:575-81. Crofford LJ. The relationship of fibromyalgia to neuropathic pain syndromes. J Rheumatol 2005; 32: 41-45.
  9. Desmeules JA, Cedraschi C, Rapiti E, Baumgartner E, Finckh A,Cohen P, et al. Neurophysiologic evidence for a central sensitization in patients with fibromyalgia. Arthritis Rheum. 2003; 48: 1420-9.
  10. Dworkin RH, Fields HL. Fibromyalgia from the perspective of neuropathic pain. J Rheumatol Suppl. 2005 Aug;75:1-5.
  11. Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA. 2004; 292: 2388-95.
  12. Gursoy S, Erdal E, Herken H, Madenci E, Alasehirli B, Erdal N.Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome. Rheumatol Int. 2003; 23: 104-7.
  13. Kooh M, Martinez-Lavin M, Meza S, Martin-del-Campo A,Hermosillo AG, Pineda C, et al. Simultaneous heart rate variability and polysomnographic analyses in fibromyalgia. Clin Exp Rheumatol. 2003;21: 5